ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1

Yang, Rui; Li, Liangliang; Hou, Yumeng; Li, Yingnan; Zhang, Jing; Yang, Na; Zhang, Yuhan; Ji, Weihang; Yu, Tong; Lv, Lifang; Liang, Haihai; Li, Xuelian; Li, Tianyu*; Shan, Hongli*内蒙古医学院; 哈尔滨医科大学; 西安交通大学; 中国医学科学院
Cell Death & Disease2023-5-30DOI: 10.1038/s41419-023-05852-7
2被引16阅读
引用收藏
分享

摘要

Cardiac hypertrophy is a common structural remodeling in many cardiovascular diseases. Recently, long non-coding RNAs (LncRNAs) were found to be involved in the physiological and pathological processes of cardiac hypertrophy. In this study, we found that LncRNA KCND1 (LncKCND1) was downregulated in both transverse aortic constriction (TAC)-induced hypertrophic mouse hearts and Angiotensin II (Ang II)-induced neonatal mouse cardiomyocytes. Further analyses showed that the knockdown of LncKCND1 impaired cardiac mitochondrial function and led to hypertrophic changes in cardiomyocytes. In contrast, overexpression of LncKCND1 inhibited Ang II-induced cardiomyocyte hypertrophic changes. Importantly, enhanced expression of LncKCND1 protected the heart from TAC-induced pathological cardiac hypertrophy and improved heart function in TAC mice. Subsequent analyses involving mass spectrometry and RNA immunoprecipitation assays showed that LncKCND1 directly binds to YBX1. Furthermore, overexpression of LncKCND1 upregulated the expression level of YBX1, while silencing LncKCND1 had the opposite effect. Furthermore, YBX1 was downregulated during cardiac hypertrophy, whereas overexpression of YBX1 inhibited Ang II-induced cardiomyocyte hypertrophy. Moreover, silencing YBX1 reversed the effect of LncKCND1 on cardiomyocyte mitochondrial function and its protective role in cardiac hypertrophy, suggesting that YBX1 is a downstream target of LncKCND1 in regulating cardiac hypertrophy. In conclusion, our study provides mechanistic insights into the functioning of LncKCND1 and supports LncKCND1 as a potential therapeutic target for pathological cardiac hypertrophy.

学科与关键词

关键词
CARDIAC-HYPERTROPHY
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Cell Death & Disease
发表日期
2023-05-30
卷期
第 14 卷, 第 5 期
页码
344
DOI
10.1038/s41419-023-05852-7
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82170299, 81900225, 81870211]; HMU Marshal Initiative Funding (China) [HMUMIF-21023]; Major Scientific Fund Project of Heilongjiang Province (China) [ZD2019H001]; CAMS Innovation Fund for Medical Sciences (CIFMS, China) [2020-I2M-5-003]

作者

  • Y

    Yang, Rui (第一作者)

    inner mongolia med univ · harbin med univ · shanghai univ engn sci

  • L

    Li, Liangliang

    harbin med univ

查看全部 14 位作者收起作者
  • H

    Hou, Yumeng

    harbin med univ

  • L

    Li, Yingnan

    xi an jiao tong univ

  • Z

    Zhang, Jing

    harbin med univ

  • Y

    Yang, Na

    harbin med univ

  • Z

    Zhang, Yuhan

    harbin med univ

  • J

    Ji, Weihang

    harbin med univ

  • Y

    Yu, Tong

    harbin med univ · shanghai univ engn sci

  • L

    Lv, Lifang

    harbin med univ

  • L

    Liang, Haihai

    harbin med univ · chinese acad med sci

  • L

    Li, Xuelian

    harbin med univ

  • L

    Li, Tianyu (通讯)

    harbin med univ

  • S

    Shan, Hongli (通讯)

    harbin med univ · shanghai univ engn sci · chinese acad med sci

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417